Nosa Med AB Cash Flow-to-Debt Ratio
Nosa Med AB cash flow-to-debt ratio. Nosa Med AB (NOSA) has a Cash Flow-to-Debt Ratio of -0.08x as of December 2025, meaning its operating cash flow of Skr-1.78 Million could theoretically repay 0% of its total liabilities (Skr23.65 Million) in one year. See how financially flexible is Nosa Med AB to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Nosa Med AB (2016–2025)
Cash flow-to-debt ratio of Nosa Med AB from 2016 to 2025. Historical debt coverage capacity for Nosa Med AB across 10 annual periods. Check how aggressively does Nosa Med AB reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Nosa Med AB Cash Flow-to-Debt Ratio by Year (2016–2025)
Nosa Med AB cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Nosa Med AB. For the full cash flow conversion analysis, see NOSA cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.27x | Skr-6.39 Million | Skr23.65 Million | ▲ +88.8% |
| 2024 | -2.42x | Skr-10.03 Million | Skr4.14 Million | ▲ +12.4% |
| 2023 | -2.76x | Skr-17.50 Million | Skr6.33 Million | ▼ -33.0% |
| 2022 | -2.08x | Skr-6.93 Million | Skr3.33 Million | ▲ +67.2% |
| 2021 | -6.33x | Skr-6.21 Million | Skr980.00K | ▼ -32.3% |
| 2020 | -4.79x | Skr-69.96 Million | Skr14.61 Million | ▼ -43.4% |
| 2019 | -3.34x | Skr-52.72 Million | Skr15.79 Million | ▼ -35.2% |
| 2018 | -2.47x | Skr-35.09 Million | Skr14.21 Million | ▲ +33.4% |
| 2017 | -3.71x | Skr-27.78 Million | Skr7.49 Million | ▲ +43.2% |
| 2016 | -6.53x | Skr-23.48 Million | Skr3.60 Million | — |